Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate a virtual Mantram repetition program for adults with PTSD and substance use disorders. The program involves repetition of a personalized Mantram, which is a word or short phrase with spiritual meaning that is frequently repeated throughout the day. The program also involves slowing down thoughts and have one-pointed attention that help with stress.


Clinical Trial Description

The purpose of this study is to evaluate a virtual Mantram repetition program for adults with PTSD and substance use disorders. The program involves repetition of a personalized Mantram, which is a word or short phrase with spiritual meaning that is frequently repeated throughout the day. The program also involves slowing down thoughts and have one-pointed attention that help with stress. The study starts with an eligibility and baseline assessment, which involves completing a series of questionnaires. Following these assessments, enrolled participants will be placed into a Mantram repetition program group led by two facilitators. This group will consist of 5 to 8 participants who will meet virtually every week for ninety minutes over an 8-week period. During this time, participants will also be asked to complete weekly self-reported questionnaires on their own. Additionally, at weeks 4 and 8, the participants will complete assessments and questionnaires with a member of the study team. The program will end after week 8. At week 12, participants will be invited to participate in a focus group to complete additional assessments, as well as be asked open-ended questions assessing the impact of the program on PTSD symptoms, substance use, and substance use cravings. In summary, the Mantram group program will take 8 weeks to complete and the assessments will take approximately 12 weeks to complete. Participants will receive compensation of up to $200 for their participation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05058963
Study type Interventional
Source Centre for Addiction and Mental Health
Contact Ahmed Hassan, MD, MPH
Phone 416-535-8501
Email [email protected]
Status Recruiting
Phase N/A
Start date May 1, 2021
Completion date April 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT04098614 - Barriers to Substance Use Disorder Recovery N/A
Completed NCT03590106 - Cardiac Surgery Peer Recovery Support Program N/A
Not yet recruiting NCT04925570 - Digital Therapeutic vs Education for the Management of Problematic Substance Use Phase 2
Recruiting NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Recruiting NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04401215 - Technologically-Augmented Referrals to Mitigate Addiction Consequences N/A
Not yet recruiting NCT04921787 - EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy N/A
Not yet recruiting NCT04691167 - the Role of Repetitive Trans Cranial-magnetic Stimulation in Craving Reduction Among Opioid Use Disorder Patients N/A
Not yet recruiting NCT04998045 - Feasibility and Acceptability of a Substance Use Screening and Brief Intervention for Youth Living With HIV in Kenya N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Active, not recruiting NCT02382042 - Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans N/A
Completed NCT01237366 - Study Targeting Affect Regulation Phase 1/Phase 2
Terminated NCT01356667 - Drum-Assisted Therapy for Native Americans N/A
Completed NCT00708890 - Twelve Step Based Self-help Groups for Substance Related Disorders N/A
Enrolling by invitation NCT04048850 - Zepatier in Patients With Substance Use
Withdrawn NCT03368794 - Naloxone to TReatment Entry in the Emergency Setting N/A
Completed NCT03226223 - Pharmacogenetics of Naltrexone for Stimulant Abuse Phase 2
Completed NCT03661580 - BA Trial for Co-Occurring Depression and Substance Use N/A
Completed NCT03356210 - Neurofeedback Training for the Treatment of Substance Use Disorders N/A
Recruiting NCT03642379 - Cardiac Surgery Peer Support Recovery N/A